Adcancing drug development: 3D CoSeedis Immuno-Micro-Tumor System
Beschreibung
This collaboration between abc biopply, ZHAW Zurich University of Applied Sciences, and University of Zurich aims to advance drug development by introducing a novel 3D CoSeedis Immuno-Micro-Tumor System.
The new system will encompass heterotypic cancer organoids, consisting of cancer, stromal and immune cells, embedded in an extracellular matrix, which offer a physiologically relevant microenvironment for testing new immunotherapies.
Eckdaten
Projektleitung
Projektteam
Projektpartner
Universität Zürich; abc biopply ag
Projektstatus
laufend, gestartet 09/2025
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT)
Drittmittelgeber
Innosuisse Innovationsprojekt